Ellagitannins-Derived Intestinal Microbial Metabolite Urolithin A Ameliorates Fructose-Driven Hepatosteatosis by Suppressing Hepatic Lipid Metabolic Reprogramming and Inducing Lipophagy-Reference-Cited by-同舟云学术

Ellagitannins-Derived Intestinal Microbial Metabolite Urolithin A Ameliorates Fructose-Driven Hepatosteatosis by Suppressing Hepatic Lipid Metabolic Reprogramming and Inducing Lipophagy

Published:2023-02-24 Issue:9 Volume:71 Page:3967-3980
ISSN:0021-8561
Container-title:Journal of Agricultural and Food Chemistry
language:en
Short-container-title:J. Agric. Food Chem.

Author:

Zhang Cong¹,Song Yingying¹,Yuan Ming¹,Chen Liang¹,Zhang Qianyu¹,Hu Junjie¹,Meng Yan¹^ORCID,Li Shan²³,Zheng Guohua⁴,Qiu Zhenpeng¹⁵^ORCID

Affiliation:

1. College of Pharmacy, Hubei University of Chinese Medicine, Wuhan 430065, People’s Republic of China

2. Hubei Key Laboratory of Wudang Local Chinese Medicine Research, Hubei University of Medicine, Shiyan 442000, People’s Republic of China

3. Department of Biochemistry, Institute of Basic Medical Sciences, Hubei University of Medicine, Shiyan 442000, People’s Republic of China

4. Key Laboratory of Chinese Medicine Resource and Compound Prescription, Ministry of Education, Hubei University of Chinese Medicine, Wuhan 430065, People’s Republic of China

5. Hubei Key Laboratory of Resources and Chemistry of Chinese Medicine, Hubei University of Chinese Medicine, Wuhan 430065, People’s Republic of China

Funder

Natural Science Foundation of Hubei Province

National Natural Science Foundation of China

Open Project of Hubei Key Laboratory of Wudang Local Chinese Medicine Research, Hubei University of Medicine

Publisher

American Chemical Society (ACS)

Subject

General Agricultural and Biological Sciences,General Chemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jafc.2c05776

Reference63 articles.

1. Mechanisms of NAFLD development and therapeutic strategies